Timed kill kinetic studies of levofloxacin, ofloxacin, and ciprofloxacin against Moraxella catarrhalis

Diagnostic Microbiology and Infectious Disease

Volumn 30, Issue 2, 1998, Pages 135-138

  Barrett, Mary S ^a   Jones, Ronald N ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORINASE; CIPROFLOXACIN; LEVOFLOXACIN; OFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; HUMANS; MORAXELLA (BRANHAMELLA) CATARRHALIS; NEISSERIACEAE; OFLOXACIN; PIPERAZINES; TIME FACTORS;

EID: 0031891699     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(97)00211-3     Document Type: Article

References (10)

1. Baltch AL, Smith RP, Ritz W. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila. Antimicrob Agents Chemother. 39:1995;1661-1666.
2. Brueggemann AB, Kugler KC, Doern GV. In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Antimicrob Agents Chemother. 41:1997;1594-1597.
3. Cormican MG, Erwin ME, Marshall SA, Jones RN. Susceptibility testing interpretive criteria for levofloxacin when testing respiratory pathogens, Haemophilus influenzae and Moraxella catarrhalis. Diagn Microbiol Infect Dis. 24:1996;155-160.
4. Davis R, Bryson HM. Levofloxacin a review of its antibacterial activity, parmacokinetics and therapeutic efficacy . Drugs. 47:1994;677-700.
5. Doern GV, Brueggemann AB, Pierce G, Hogan T, Holley HP Jr, Rauch A. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995 results of a 30-center national surveillance study . Antimicrob Agents Chemother. 40:1996;2884-2886.
6. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically approved standard M7-A4, 4th ed . 1997;NCCLS, Wayne, PA.
7. Methods for determining bactericidal activity of antimicrobial agents, tentative guidelines M26-P. 1997;National Committee for Clinical Laboratory Standards, Wayne, PA.
8. Performance standards for antimicrobial susceptibility testing, 8th information supplement, M100-S8. 1998;NCCLS, Wayne, PA.
9. Pankuch GA, Lichtenberger C, Jacobs MR, Appelbaum PC. Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies. Antimicrob Agents Chemother. 40:1996;1653-1656.
10. Visalli MA, Jacobs MR, Appelbaum PC. MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother. 40:1996;362-366.